Highland Capital Management (Texas)’s bluebird bio BLUE Stock Holding History

Highland Capital Management (Texas)’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-154	Closed	-$292K	–	276
2018 Q3	$292K	Hold	154	–	–	0.02%	276
2018 Q2	$314K	Sell	154 -217	-58%	-$495K	0.02%	265
2018 Q1	$820K	Sell	371 -1,057	-74%	-$2.69M	0.04%	194
2017 Q4	$3.29M	Sell	1,428 -371	-21%	-$753K	0.15%	126
2017 Q3	$3.2M	Buy	+1,799	New	+$2.51M	0.14%	124
2017 Q2	–	Sell	-3,011	Closed	-$3.54M	–	294
2017 Q1	$3.54M	Sell	3,011 -1,119	-27%	-$1.14M	0.18%	118
2016 Q4	$3.3M	Buy	+4,130	New	+$3.28M	0.16%	119

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Highland Capital Management (Texas)'s BLUE Position: Q4 2018 in Review

Highland Capital Management (Texas) sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 154 shares — an estimated $292K sold.

Highland Capital Management (Texas) first reported a position in BLUE in Q4 2016 and held it in 7 quarters. The position peaked at $3.54M in Q1 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

Highland Capital Management (Texas) reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
Highland Capital Management (Texas) sold 154 bluebird bio shares in Q4 2018, an estimated $292K.
Highland Capital Management (Texas) first reported a position in bluebird bio in Q4 2016 and held it in 7 quarters.
Highland Capital Management (Texas)'s bluebird bio position peaked at $3.54M in Q1 2017.
251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2018, filed 13 Feb 2019.